webinars

UPCOMING WEBINAR

Expanding Peptide Drug Discovery with Next-Generation Peptide DELs

Peptide therapeutics offer highly specific and versatile treatments for complex and previously undruggable targets. High-throughput peptide library screening has accelerated discovery. However, traditional platforms such as phage or mRNA display are inherently limited by biological translation processes. DNA-encoded library (DEL) technology provides an alternative, enabling incorporation of unnatural amino acids and diverse cyclization strategies, and producing peptides with improved stability and prolonged retention.
Register Now
PAST WEBINARS

Metabolic Instability of Peptide Therapeutics: Mechanisms, Analytical Strategies, and Design Solutions for Clinical Success

Metabolic instability is a key challenge in developing peptide therapeutics, and factors like rapid clearance and complex, multi-pathway biotransformation can further limit their effectiveness. Understanding and addressing these hurdles can unlock the full potential of peptide drugs, enabling them to reach challenging biological targets, support rational chemical design, and achieve clinical success. This webinar presents an integrated mechanism–analytics–design perspective to tackle these challenges and accelerate peptide drug discovery.
Watch Now
PAST WEBINARS

Accelerating Clinical Entry for Poorly Soluble Molecules: A Proven and Structured Roadmap

Poorly soluble molecules face unique challenges that can slow development and limit clinical success. Early formulation decisions are critical for determining bioavailability, in vivo exposure and the speed to IND submission and first-in-human studies. This webinar will show how tailored early-phase strategies, aligned with molecule properties and clinical stage, can overcome solubility, bioavailability limitations and related formulation challenges.
Watch Now
PAST WEBINARS

High Translatable DIO Rodent Model: Accelerating Weight Loss Drug Discovery

Obesity remains a critical global health threat, affecting over one billion people worldwide and exacerbating risks for type 2 diabetes, cardiovascular diseases, and fatty liver disease. The pharmaceutical landscape is witnessing rapid transformation through novel oral GLP-1 agents, long-acting injectables, and multi-target therapies that are redefining treatment possibilities.
Watch Now
PAST WEBINARS

ADME and Bioanalytical Strategies for ADCs: Challenges, Emerging Technologies, and Regulatory Considerations

Antibody-drug conjugates (ADCs) are transforming cancer treatment, but their development brings unique challenges in the DMPK field, including ADME, bioanalysis, and regulatory registration. This webinar explores integrated DMPK and bioanalytical strategies for ADC discovery and development, grounded in recent analytical advances, global guidelines, and real-world experience.
Watch Now
PAST WEBINARS

Clinical Trial Application Success: CMC and Regulatory Insights from the US to Europe

The Investigational New Drug (IND) application in the US and Clinical Trial Application (CTA) in Europe are key milestones in advancing innovative therapies to clinical development. This webinar will discuss the technical and regulatory aspects of IND and CTA submissions in the US and Europe.
Watch Now
Total 19 1234
✉️Contact Us
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all